Tb. Mcclanahan et al., EFFECTS OF ENDOTHELIN-RECEPTOR ANTAGONISM WITH PD156707 ON MYOCARDIALSTUNNING IN SWINE, Journal of cardiovascular pharmacology, 28(5), 1996, pp. 679-686
Endothelin (ET) has been proposed to play a role in the pathogenesis o
f myocardial ischemia/reperfusion injury. The potential role of ET in
myocardial stunning has not been examined, Therefore we tested the hyp
othesis that selective blockade of ETA receptors with PD156707 {sodium
2-benzo[1,3]dioxol-5-yl-4-(4-methoxy-phenyl)-4-oxo -3-(3,4,5-trimetho
xy-benzyl)-but-2-enoate} could improve postischemic contractile dysfun
ction in open-chest pigs, Myocardial stunning was achieved by a sequen
ce of three 10-min left anterior descending (LAD) occlusions intersper
sed with 15 min of reperfusion, All pigs received either an intravenou
s saline vehicle (n = 6) or PD156707 (n = 6) at a loading dose infusio
n of 10 mg/kg/h for 1 h before the first occlusion followed by a maint
enance dose of 7 mg/kg/h for 4 h. Systolic wall thickening (percentage
of baseline) was measured with sonomicrometers. There was no signific
ant difference in systolic thickening between groups at baseline, at t
he end of the final stunning occlusion, or at any of the time points d
uring reperfusion. PD156707 significantly reduced arterial blood press
ure before myocardial ischemia and throughout reperfusion. There was n
o significant difference in size of the region at risk between groups.
In conclusion, selective blockade of ETA receptors with PD156707 did
not significantly alter postischemic contractile function in open-ches
t pigs. These results suggest that activation of ETA receptors by endo
genous ET does not play a significant role in the pathogenesis of myoc
ardial stunning.